Do analysts recommend MCK or RDGT?

McKesson presently has a consensus target price of $968.93, suggesting a potential upside of 8.57%. Given McKesson's stronger consensus rating and higher possible upside, research analysts plainly believe McKesson is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score McKesson 0 Sell rating(s) 3 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.82 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, MCK or RDGT?

McKesson has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio McKesson $403.43B 0.26 $4.76B $37.37 23.88 Ridgetech $132.16M 0.02 -$1.25M N/A N/A

Is MCK or RDGT more profitable?

McKesson has a net margin of 1.12% compared to Ridgetech's net margin of 0.00%. Ridgetech's return on equity of 0.00% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets McKesson 1.12% -253.21% 5.90% Ridgetech N/A N/A N/A

Does the media prefer MCK or RDGT?

In the previous week, McKesson had 51 more articles in the media than Ridgetech. MarketBeat recorded 52 mentions for McKesson and 1 mentions for Ridgetech. McKesson's average media sentiment score of 0.96 beat Ridgetech's score of 0.00 indicating that McKesson is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment McKesson 29 Very Positive mention(s) 10 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Ridgetech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate COR or RDGT?

Cencora currently has a consensus target price of $368.92, suggesting a potential upside of 13.50%. Given Cencora's stronger consensus rating and higher probable upside, analysts clearly believe Cencora is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cencora 0 Sell rating(s) 2 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.87 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, COR or RDGT?

Cencora has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cencora $321.33B 0.20 $1.55B $13.46 24.15 Ridgetech $132.16M 0.02 -$1.25M N/A N/A

Is COR or RDGT more profitable?

Cencora has a net margin of 0.79% compared to Ridgetech's net margin of 0.00%. Cencora's return on equity of 125.45% beat Ridgetech's return on equity. Company Net Margins Return on Equity Return on Assets Cencora 0.79% 125.45% 4.18% Ridgetech N/A N/A N/A

Does the media prefer COR or RDGT?

In the previous week, Cencora had 27 more articles in the media than Ridgetech. MarketBeat recorded 28 mentions for Cencora and 1 mentions for Ridgetech. Cencora's average media sentiment score of 0.76 beat Ridgetech's score of 0.00 indicating that Cencora is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 8 Very Positive mention(s) 6 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Ridgetech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate RDGT or CAH?

Cardinal Health has a consensus target price of $251.73, indicating a potential upside of 6.03%. Given Cardinal Health's stronger consensus rating and higher possible upside, analysts plainly believe Cardinal Health is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cardinal Health 0 Sell rating(s) 3 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.83

Which has higher valuation & earnings, RDGT or CAH?

Cardinal Health has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.02 -$1.25M N/A N/A Cardinal Health $250.74B 0.22 $1.56B $6.54 36.30

Does the media refer more to RDGT or CAH?

In the previous week, Cardinal Health had 7 more articles in the media than Ridgetech. MarketBeat recorded 8 mentions for Cardinal Health and 1 mentions for Ridgetech. Cardinal Health's average media sentiment score of 0.61 beat Ridgetech's score of 0.00 indicating that Cardinal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ridgetech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cardinal Health 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer HSIC or RDGT?

Henry Schein presently has a consensus price target of $92.27, indicating a potential upside of 4.78%. Given Henry Schein's stronger consensus rating and higher probable upside, equities analysts plainly believe Henry Schein is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Henry Schein 1 Sell rating(s) 6 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.47 Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, HSIC or RDGT?

Henry Schein has higher revenue and earnings than Ridgetech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Henry Schein $13.18B 0.74 $398M $3.43 25.67 Ridgetech $132.16M 0.02 -$1.25M N/A N/A

Does the media prefer HSIC or RDGT?

In the previous week, Henry Schein had 28 more articles in the media than Ridgetech. MarketBeat recorded 29 mentions for Henry Schein and 1 mentions for Ridgetech. Henry Schein's average media sentiment score of 0.60 beat Ridgetech's score of 0.00 indicating that Henry Schein is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 8 Very Positive mention(s) 5 Positive mention(s) 11 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Ridgetech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate RDGT or AHCO?

AdaptHealth has a consensus price target of $10.29, indicating a potential upside of 88.21%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Ridgetech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AdaptHealth 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67

Which has preferable earnings & valuation, RDGT or AHCO?

Ridgetech has higher earnings, but lower revenue than AdaptHealth. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.02 -$1.25M N/A N/A AdaptHealth $3.24B 0.23 -$70.79M -$1.71 N/A

Does the media favor RDGT or AHCO?

In the previous week, AdaptHealth had 25 more articles in the media than Ridgetech. MarketBeat recorded 26 mentions for AdaptHealth and 1 mentions for Ridgetech. AdaptHealth's average media sentiment score of 0.01 beat Ridgetech's score of 0.00 indicating that AdaptHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ridgetech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AdaptHealth 5 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 4 Negative mention(s) 3 Very Negative mention(s) Neutral

Ridgetech (RDGT) Competitors

$0.74 -0.01 (-0.78%)

As of 10:48 AM Eastern

Compare

RDGT vs. MCK, COR, CAH, HSIC, and AHCO

Should you buy Ridgetech stock or one of its competitors? MarketBeat compares Ridgetech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ridgetech include McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), and AdaptHealth (AHCO). These companies are all part of the "healthcare distributors" industry.

How does Ridgetech compare to McKesson?

McKesson (NYSE:MCK) and Ridgetech (NASDAQ:RDGT) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings.

McKesson presently has a consensus target price of $968.93, suggesting a potential upside of 8.57%. Given McKesson's stronger consensus rating and higher possible upside, research analysts plainly believe McKesson is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, McKesson had 51 more articles in the media than Ridgetech. MarketBeat recorded 52 mentions for McKesson and 1 mentions for Ridgetech. McKesson's average media sentiment score of 0.96 beat Ridgetech's score of 0.00 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	29 Very Positive mention(s)	10 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Ridgetech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

McKesson has a net margin of 1.12% compared to Ridgetech's net margin of 0.00%. Ridgetech's return on equity of 0.00% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	1.12%	-253.21%	5.90%
Ridgetech	N/A	N/A	N/A

McKesson has a beta of 0.3, indicating that its stock price is 70% less volatile than the broader market. Comparatively, Ridgetech has a beta of -0.13, indicating that its stock price is 113% less volatile than the broader market.

McKesson has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$403.43B	0.26	$4.76B	$37.37	23.88
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A

85.1% of McKesson shares are owned by institutional investors. Comparatively, 45.3% of Ridgetech shares are owned by institutional investors. 0.1% of McKesson shares are owned by company insiders. Comparatively, 22.6% of Ridgetech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

McKesson beats Ridgetech on 12 of the 14 factors compared between the two stocks.

How does Ridgetech compare to Cencora?

Cencora (NYSE:COR) and Ridgetech (NASDAQ:RDGT) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

97.5% of Cencora shares are owned by institutional investors. Comparatively, 45.3% of Ridgetech shares are owned by institutional investors. 0.4% of Cencora shares are owned by company insiders. Comparatively, 22.6% of Ridgetech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Cencora currently has a consensus target price of $368.92, suggesting a potential upside of 13.50%. Given Cencora's stronger consensus rating and higher probable upside, analysts clearly believe Cencora is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.87
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cencora has a beta of 0.57, suggesting that its stock price is 43% less volatile than the broader market. Comparatively, Ridgetech has a beta of -0.13, suggesting that its stock price is 113% less volatile than the broader market.

Cencora has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.20	$1.55B	$13.46	24.15
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A

In the previous week, Cencora had 27 more articles in the media than Ridgetech. MarketBeat recorded 28 mentions for Cencora and 1 mentions for Ridgetech. Cencora's average media sentiment score of 0.76 beat Ridgetech's score of 0.00 indicating that Cencora is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	8 Very Positive mention(s)	6 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Ridgetech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cencora has a net margin of 0.79% compared to Ridgetech's net margin of 0.00%. Cencora's return on equity of 125.45% beat Ridgetech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.79%	125.45%	4.18%
Ridgetech	N/A	N/A	N/A

Summary

Cencora beats Ridgetech on 13 of the 14 factors compared between the two stocks.

How does Ridgetech compare to Cardinal Health?

Ridgetech (NASDAQ:RDGT) and Cardinal Health (NYSE:CAH) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

Cardinal Health has a consensus target price of $251.73, indicating a potential upside of 6.03%. Given Cardinal Health's stronger consensus rating and higher possible upside, analysts plainly believe Cardinal Health is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.83

Ridgetech has a beta of -0.13, indicating that its stock price is 113% less volatile than the broader market. Comparatively, Cardinal Health has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market.

In the previous week, Cardinal Health had 7 more articles in the media than Ridgetech. MarketBeat recorded 8 mentions for Cardinal Health and 1 mentions for Ridgetech. Cardinal Health's average media sentiment score of 0.61 beat Ridgetech's score of 0.00 indicating that Cardinal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ridgetech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cardinal Health	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Cardinal Health has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A
Cardinal Health	$250.74B	0.22	$1.56B	$6.54	36.30

Cardinal Health has a net margin of 0.62% compared to Ridgetech's net margin of 0.00%. Ridgetech's return on equity of 0.00% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Cardinal Health	0.62%	-92.61%	4.46%

45.3% of Ridgetech shares are held by institutional investors. Comparatively, 87.2% of Cardinal Health shares are held by institutional investors. 22.6% of Ridgetech shares are held by insiders. Comparatively, 0.1% of Cardinal Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Cardinal Health beats Ridgetech on 12 of the 14 factors compared between the two stocks.

How does Ridgetech compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Ridgetech (NASDAQ:RDGT) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 45.3% of Ridgetech shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 22.6% of Ridgetech shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Henry Schein had 28 more articles in the media than Ridgetech. MarketBeat recorded 29 mentions for Henry Schein and 1 mentions for Ridgetech. Henry Schein's average media sentiment score of 0.60 beat Ridgetech's score of 0.00 indicating that Henry Schein is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	8 Very Positive mention(s)	5 Positive mention(s)	11 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Ridgetech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Henry Schein has higher revenue and earnings than Ridgetech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.74	$398M	$3.43	25.67
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A

Henry Schein presently has a consensus price target of $92.27, indicating a potential upside of 4.78%. Given Henry Schein's stronger consensus rating and higher probable upside, equities analysts plainly believe Henry Schein is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.47
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Henry Schein has a net margin of 2.96% compared to Ridgetech's net margin of 0.00%. Henry Schein's return on equity of 15.97% beat Ridgetech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Ridgetech	N/A	N/A	N/A

Henry Schein has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, Ridgetech has a beta of -0.13, meaning that its stock price is 113% less volatile than the broader market.

Summary

Henry Schein beats Ridgetech on 13 of the 14 factors compared between the two stocks.

How does Ridgetech compare to AdaptHealth?

Ridgetech (NASDAQ:RDGT) and AdaptHealth (NASDAQ:AHCO) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability.

Ridgetech has a beta of -0.13, indicating that its share price is 113% less volatile than the broader market. Comparatively, AdaptHealth has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market.

In the previous week, AdaptHealth had 25 more articles in the media than Ridgetech. MarketBeat recorded 26 mentions for AdaptHealth and 1 mentions for Ridgetech. AdaptHealth's average media sentiment score of 0.01 beat Ridgetech's score of 0.00 indicating that AdaptHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ridgetech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AdaptHealth	5 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	4 Negative mention(s)	3 Very Negative mention(s)	Neutral

Ridgetech has higher earnings, but lower revenue than AdaptHealth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A
AdaptHealth	$3.24B	0.23	-$70.79M	-$1.71	N/A

Ridgetech has a net margin of 0.00% compared to AdaptHealth's net margin of -7.07%. AdaptHealth's return on equity of 3.36% beat Ridgetech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
AdaptHealth	-7.07%	3.36%	1.16%

45.3% of Ridgetech shares are held by institutional investors. Comparatively, 82.7% of AdaptHealth shares are held by institutional investors. 22.6% of Ridgetech shares are held by company insiders. Comparatively, 2.0% of AdaptHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

AdaptHealth has a consensus price target of $10.29, indicating a potential upside of 88.21%. Given AdaptHealth's stronger consensus rating and higher probable upside, analysts clearly believe AdaptHealth is more favorable than Ridgetech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AdaptHealth	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

AdaptHealth beats Ridgetech on 11 of the 14 factors compared between the two stocks.

Get Ridgetech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDGT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RDGT vs. The Competition

Export

Metric	Ridgetech	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.69M	$10.05B	$7.02B	$12.96B
Dividend Yield	N/A	2.55%	2.58%	10.20%
P/E Ratio	N/A	25.57	269.90	24.97
Price / Sales	0.02	4.83	659.13	107.89
Price / Cash	N/A	25.58	28.89	37.44
Price / Book	0.02	5.32	11.29	6.44
Net Income	-$1.25M	$309.96M	$3.45B	$347.50M
7 Day Performance	-3.04%	0.86%	3.56%	3.82%
1 Month Performance	-50.99%	0.29%	-0.57%	-0.37%
1 Year Performance	-99.60%	23.75%	77.67%	23.81%

Ridgetech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RDGT Ridgetech	0.4872 of 5 stars	$0.74 -0.8%	N/A	-99.6%	$2.69M	$132.16M	N/A	980	Gap Up
MCK McKesson	4.838 of 5 stars	$874.01 +5.2%	$962.67 +10.1%	+30.7%	$102.33B	$403.43B	22.72	43,000	Earnings Report Analyst Forecast
COR Cencora	4.8359 of 5 stars	$317.68 +3.7%	$367.75 +15.8%	+12.3%	$61.81B	$321.33B	24.36	51,000	Earnings Report Dividend Announcement Analyst Forecast
CAH Cardinal Health	4.5181 of 5 stars	$239.32 +2.5%	$251.73 +5.2%	+50.3%	$56.05B	$222.58B	36.59	57,700	Upcoming Earnings
HSIC Henry Schein	3.5482 of 5 stars	$89.59 +0.5%	$91.33 +1.9%	+33.7%	$10.21B	$13.38B	27.07	25,000	Earnings Report Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RDGT) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ridgetech (RDGT) Competitors

RDGT vs. MCK, COR, CAH, HSIC, and AHCO

How does Ridgetech compare to McKesson?

Summary

How does Ridgetech compare to Cencora?

Summary

How does Ridgetech compare to Cardinal Health?

Summary

How does Ridgetech compare to Henry Schein?

Summary

How does Ridgetech compare to AdaptHealth?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDGT vs. The Competition

Ridgetech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ridgetech (RDGT) Competitors

RDGT vs. MCK, COR, CAH, HSIC, and AHCO

How does Ridgetech compare to McKesson?

Do analysts recommend MCK or RDGT?

Does the media prefer MCK or RDGT?

Is MCK or RDGT more profitable?

Which has more volatility & risk, MCK or RDGT?

Which has stronger valuation and earnings, MCK or RDGT?

Do insiders & institutionals hold more shares of MCK or RDGT?

Summary

How does Ridgetech compare to Cencora?

Do institutionals & insiders hold more shares of COR or RDGT?

Do analysts rate COR or RDGT?

Which has more risk and volatility, COR or RDGT?

Which has higher earnings and valuation, COR or RDGT?

Does the media prefer COR or RDGT?

Is COR or RDGT more profitable?

Summary

How does Ridgetech compare to Cardinal Health?

Do analysts rate RDGT or CAH?

Which has more risk & volatility, RDGT or CAH?

Does the media refer more to RDGT or CAH?

Which has higher valuation & earnings, RDGT or CAH?

Is RDGT or CAH more profitable?

Do insiders and institutionals believe in RDGT or CAH?

Summary

How does Ridgetech compare to Henry Schein?

Do institutionals & insiders believe in HSIC or RDGT?

Does the media prefer HSIC or RDGT?

Which has stronger valuation & earnings, HSIC or RDGT?

Do analysts prefer HSIC or RDGT?

Is HSIC or RDGT more profitable?

Which has more risk & volatility, HSIC or RDGT?

Summary

How does Ridgetech compare to AdaptHealth?

Which has more risk & volatility, RDGT or AHCO?

Does the media favor RDGT or AHCO?

Which has preferable earnings & valuation, RDGT or AHCO?

Is RDGT or AHCO more profitable?

Do insiders & institutionals have more ownership in RDGT or AHCO?

Do analysts rate RDGT or AHCO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDGT vs. The Competition

Ridgetech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools